White House
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
White House Unveils ADAPT Program to Advance Biomarker-Guided Cancer Treatment
As part of ARPA-H, ADAPT will fund research into biomarker strategies that adapt to changing tumor biology and ways to translate them into clinical trials.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
US Department of Defense Adds BGI Genomics to Blacklist of 'Chinese Military Companies'
Companies placed on the list last year were banned from investment opportunities in the US by an executive order signed by President Joe Biden.
President Biden Proposes 10 Percent Boost in NIH Funding for Fiscal 2023
Though the National Institutes of Health overall would see a boost, the NCI and NHGRI would see funding cuts under the proposal.